Related Experiment Video
Updated: Mar 12, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging
Yu Zhang1,2, I-Wei Wu1,2, Duygu Tosun1,2
1Department of Veteran Affairs Medical Center, San Francisco, California, United States of America.
Diffusion tensor imaging (DTI) reveals significant microstructural changes in Parkinson's disease (PD) patients. These DTI variations, particularly in the substantia nigra and thalamus, may serve as early markers for PD progression.
Area of Science:
- Neuroimaging
- Neurology
- Biomarkers
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- Identifying reliable markers for PD progression is crucial for effective management.
- Diffusion tensor imaging (DTI) offers insights into white matter microstructure.
Purpose of the Study:
- To evaluate the utility of DTI in quantifying microstructural progression in de-novo PD patients.
- To assess regional DTI changes and their correlation with clinical and biomarker data.
Main Methods:
- Longitudinal DTI scans from 122 de-novo PD patients and 50 controls (Parkinson's Progression Markers Initiative).
- Automated image processing for intra- and inter-subject registration.
- Estimation of annualized DTI variations (FA, rD, aD) in 118 regions of interest.
Main Results:
- PD patients showed accelerated FA reduction and diffusivity increases compared to controls, predominantly in the substantia nigra, midbrain, and thalamus.
- Substantia nigra showed highest FA reduction (3.6%/year); thalamus showed highest diffusivity increase (rD: 8.0%/year).
- DTI changes correlated with dopaminergic deficits, CSF biomarkers (α-synuclein, tau), and cognitive decline in PD.
Conclusions:
- Regional microstructural degeneration, as measured by DTI, represents potential markers for Parkinson's disease progression.
- DTI metrics can track disease-related changes in specific brain regions.
- DTI may aid in monitoring PD progression and treatment response.
More Related Videos
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
06:09Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...